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Abstract
Objective: The AVOID-FFS (Avoidance of Far-Field R-wave Sensing) study aimed to investigate whether an atrial lead with a
very short tip-to-ring spacing without optimization of pacemaker settings shows equally low incidence of far-field R-wave
sensing (FFS) when compared to a conventional atrial lead in combination with optimization of the programming.
Methods: Patients receiving a dual chamber pacemaker were randomly assigned to receive an atrial lead with a tip-to-ring
spacing of 1.1 mm or a lead with a conventional tip-to-ring spacing of 10 mm. Postventricular atrial blanking (PVAB) was
programmed to the shortest possible value of 60 ms in the study group, and to an individually determined optimized value
in the control group. Atrial sensing threshold was programmed to 0.3 mV in both groups. False positive mode switch
caused by FFS was evaluated at one and three months post implantation.
Results: A total of 204 patients (121 male; age 73610 years) were included in the study. False positive mode switch caused
by FFS was detected in one (1%) patient of the study group and two (2%) patients of the control group (p=0.62).
Conclusion: The use of an atrial electrode with a very short tip-to-ring spacing avoids inappropriate mode switch caused by
FFS without the need for individual PVAB optimization.
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Introduction
Diagnostic features of modern pacemakers are frequently used
in monitoring the clinical status of patients including the potential
occurrence of atrial tachyarrhythmias [1–6]. In this setting,
derived data logs displaying mode switch event frequency and
duration provide assistance when deciding whether or not
antiarrhythmic or anticoagulation treatment is indicated. Howev-
er, this decision making is highly dependant on the reliability of the
data provided by the device. Far-field R-wave sensing (FFS) has
been identified as the most common cause of inappropriate mode
switch in dual chamber pacemakers [7,8]. False positive mode
switches can result in a loss of atrioventricular synchrony in
atrioventricular block and can cause impaired hemodynamics,
potential proarrhythmic effects, and pacemaker syndrome. It may
also lead to commencement of unnecessary antiarrhythmic
medication, interventional therapy or anticoagulation.
Current strategies to avoid inappropriate mode switch from
DDD(R) to DDI(R) mode and to optimize the quality of stored
data include the programming of a reduced atrial sensitivity [9,10]
or the individual adjustment of the postventricular atrial blanking
period (PAVB) [8,10–12]. Each of these strategies encounters its
own problems. Reducing the atrial sensitivity runs the risk of
undersensing during atrial tachyarrhythmias [13,14] and can
therefore end in an underestimation of the atrial tachyarrhythmia
burden. Adjusting the PVAB – although highly effective in
avoiding inappropriate mode switch [8,10–12] – encounters some
extra time for individual optimization of the parameter in follow-
up visits and it is not devoid of tachyarrhythmia misclassification as
a 2:1 lock-in of atrial signals may occur with atrial flutter [15].
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38277Recent studies have shown that reducing the inter-electrode tip-
to-ring spacing of atrial bipolar leads reduces the amplitude of far-
field R-wave and consequently the occurrence of inappropriate
mode switches [16,17]. With the availability of new leads
providing a very short tip-to-ring distance of 1.1 mm instead of
traditional 10 mm spacing, FFS may be further reduced [18–20]
and individual adjustment of pacemaker settings may no longer
necessary to avoid FFS.
Therefore, the aim of the prospective, randomized AVOID-FFS
study was to compare the incidence of inappropriate mode switch
due to FFS between pacemaker systems supplied with an atrial
lead of a very short bipole electrode spacing (1.1 mm) to those with
a standard spacing (10 mm). The comparison was done under the
precondition that in pacemaker systems with the very short atrial
inter-electrode spacing the PVAB was programmed at 60 ms
without any further adjustment, whereas in pacemaker systems
using atrial electrodes with conventional bipole spacing the PVAB
was individually optimized according to an additional test.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1. A total of 10 centers participated in the AVOID-FFS
study between February 2007 and May 2009 (ClinicalTrials.gov
identifier: NCT00512915). Patients with indication for dual
chamber pacing (according to national or international guidelines)
and receiving an Identity (ADx) DR or Victory DR pacemaker (St.
Jude Medical, Sylmar, CA, USA) were eligible for the study. They
were randomly assigned (1:1 allocation in blocks of four in
centrally generated sealed envelopes) to receive a novel atrial lead
with a very short tip-to-ring distance (OptiSense
TM 1699T or
1999T, both from St. Jude Medical, Sylmar, CA, USA) or a
conventional atrial lead (Tendril
TM 1388T, 1688T, 1788T or
1888T, all from St. Jude Medical, Sylmar, CA, USA). All of these
steroid-eluting, active fixation leads are characterized by practi-
cally identical values for cathode and anode surface and amount of
helix extension, but the leads differ in the spacing between the
distal tip electrode and the proximal ring electrode which is
1.1 mm for the OptiSense
TM leads and 10 mm for the other leads.
All leads were implanted according to standard protocols and
the atrial implant site was left at the discretion of the implanting
physician.
All patients gave their written informed consent for the study
procedure, and the trial was approved by the ethics committee of
the Technische Universita ¨t Mu ¨nchen, Munich, Germany (project
number 1694/07) and it was conducted under the conditions laid
out in the declaration of Helsinki.
Patients with persistent or permanent atrial tachyarrhythmias,
patients undergoing a pacemaker replacement or those not
available for follow-up visits as well as minors were excluded
from the study. Other exclusion criteria were pregnancy, mental
disability, history of cardiac surgery or myocardial infarction
within 4 weeks prior to enrolment or planned cardiac surgery
within the next 3 months after randomization.
Study Protocol
In both groups pacemakers were programmed to the DDD(R)
mode and atrioventricular delays were optimized (mere prolon-
gation or use of the hysteresis algorithm) to allow intrinsic
atrioventricular conduction if present. The atrial sensitivity level
was set to 0.3 mV and mode switch was enabled for atrial rates
greater than 180 bpm according to the filtered atrial rate interval
used in St. Jude Medical pacemakers. The trigger to store an
electrogram in the pacemaker was activated for mode switch and
all other triggers were turned off.
In the control group PVAB was optimized according to a far-
field R-wave sensing test. For this test the atrial sensitivity was
temporarily set to 0.1 mV and PVAB to the lowest setting of
60 ms. FFS was provoked during ventricular stimulation. The
optimized PVAB setting was defined as the interval between the
ventricular pacing marker and the detection of a far-field R-wave
signal (corresponding to an atrial event sensed in the refractory
period) plus 25 ms. If no far-field R-wave signal was detected by
the pacemaker, the optimized PVAB was set to 85 ms. In the study
group receiving the lead with the very short bipole distance this
optimizing test was not applied and the PVAB was fixedly
programmed to a value of 60 ms. Additionally, in both groups
sensing threshold, pacing threshold, and lead impedance were
determined at discharge, one month and three months after
pacemaker implantation.
The primary endpoint of the study was the occurrence of
inappropriate mode switch due to FFS assessed by stored
electrograms of the pacemaker within the first 3 months after
implantation.
The secondary endpoints of the study were fluoroscopy time
and cut-to-suture time during implantation, lead parameters
during follow-up, the influence of the atrial lead position and the
ventricular pacing percentage on the occurrence of inappropriate
mode switch caused by FFS, and the occurrence of symptomatic
2:1 lock-in of atrial flutter.
Inappropriate Mode Switch Due to FFS
Atrial far-field R-wave signals were defined as atrial signals that
were unrelated to an intrinsic atrial activation but were related to a
ventricular depolarization. These far-field signals differ in size,
morphology and potentially in polarity from the atrial near-field
signal. In contrast to supraventricular premature beats there is a
constant coupling interval between a ventricular event and the
atrial far-field signal for each form of ventricular depolarization
(ventricular paced beat, intrinsic atrioventricular conduction,
ventricular premature beats of same origin).
Statistical Analysis and Sample Size Calculation
Based on previous published results the incidence of inappro-
priate mode switch due to FFS is 5% among patients with
individual optimization of the PVAB [8]. Given a significance level
of 5%, a power of 80%, and the lower limit of the observed 95%
confidence interval exceeding 210%, a total of 75 complete data
sets per group were calculated to determine non-inferiority.
Including drop outs of 10%, a total of 168 patients (84 per group)
were planned to be enrolled.
Statistical analyses were performed using the software SAS 9.2
for windows (SAS Institute Inc., Cary, NC, USA.). Continuous
data are presented as mean 6 standard deviation, and compar-
isons between the groups were carried out using the Student’s t-
test or the Wilcoxon test, where appropriate. Categorical variables
are presented as frequencies and percentages and comparisons
between the groups were performed using the Chi-square test or
Fisher’s exact test, where appropriate. P-values ,0.05 were
considered statistically significant. Data were evaluated on an
intention-to-treat basis.
Results
Study Population
A total of 204 patients (121 (59%) male, 83 (41%) female, mean
age 73610 years) were included in the study; 103 patients were
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group, respectively. Complete data sets for the primary endpoint
were available for 100 patients of the study group and 98 patients
of the control group. Further information on recruitment and
study conduct are given in Fig. 1. Baseline characteristics did not
differ between the two groups and are shown in Table 1.
Figure 1. Study flow-chart.
doi:10.1371/journal.pone.0038277.g001
AVOID-FFS Study
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The primary endpoint of inappropriate mode switch due to FFS
(Fig. 2) was detected in 1/100 (1%) patient of the study group and
in 2/98 (2%) patients of the control group (p=0.62). For this
comparison the median or mean value (range) of the PVAB were
60 ms or 68 ms (60–150 ms) for the study group and 128 ms or
121 ms (85 to 195 ms) for the control group (p,0.005). Due to
erroneous programming the PVAB exceeded the value of 60 ms,
which was specified in the trial protocol, in nine patients of the
study group. This false PVAB setting was corrected in eight out of
nine individuals at the one month follow-up visit. In one patient of
the study group, the PVAB was individually optimized and
prolonged after the occurrence of inappropriate mode switch at a
setting of 60 ms. The distribution of applied PVAB is summarized
in Fig. 3.
The 95% confidence interval for the difference between the two
groups in terms of rate of inappropriate mode switch is (24%,
2%). This confidence interval is above the non-inferiority margin,
therefore non-inferiority of the study group can be concluded.
Secondary Endpoints
As shown in the baseline characteristics (Table 1), fluoroscopy
time and procedure time did not differ between the two groups.
Furthermore, all leads could be successfully placed according to
the randomization. At discharge, P-wave amplitudes of OptiSen-
se
TM electrodes were lower than those of conventional atrial leads.
This difference remained constant over the three months follow-up
period. Atrial pacing thresholds were significantly lower in the
OptiSense
TM group during the whole study duration and lead
impedances were constantly higher in the OptiSense
TM group
during the follow-up period reaching statistical significance for the
measurements at discharge (Table 2). Due to the small number of
patients meeting the primary endpoint a subgroup analysis could
not be run in order to identify potential risk factors for the
occurrence of inappropriate mode switch such as the atrial lead
position or the ventricular pacing percentage. In none of the
patients a symptomatic 2:1 lock-in of atrial flutter was observed.
Discussion
The main results of the present randomized multicenter study
on the efficacy of very short tip-to-ring atrial electrodes to avoid
FFS compared to conventional atrial leads can be summarized as
follows: 1.) in both groups the incidence of false positive mode
switch induced by FFS was comparably low 2.) the low incidence
of inappropriate mode switch due to FFS was attained despite a
fixed short PVAB setting of 60 ms in the very short tip-to-ring
electrode group and through individually prolonged PVAB
intervals in the control group. 3.) electrical performance of the
atrial leads with very short tip-to-ring distance did not vary during
the three months follow-up period, and 4.) in detail, P-wave
amplitudes were smaller in the study group, but were yet in a
clinically acceptable range. Furthermore, lower pacing threshold
during follow-up could be seen in the study group.
The very few episodes of inappropriate mode switch in the study
group (OptiSense
TM lead) indirectly confirm the results of two
recent investigations [18,19] which found reduced ventricular far-
field R-wave amplitudes in the atrium using the OptiSense
TM
electrode. Another study proved a significant decrease of
inappropriate mode switch due to FFS by using a pacemaker
system with an OptiSense
TM lead compared to controls with
standard leads which - however – settings were not optimized for
the PVAB or the atrial sensing threshold [20]. In contrast to these
reports, the present randomized trial is the first to compare the
occurrence of inappropriate mode switch due to FFS with a group
of patients who received a standard atrial electrode but underwent
an individual optimization of the device programming, which
should be regarded as ‘‘gold standard’’ in clinical practice.
The very low incidence of inappropriate mode switch caused by
FFS in the OptiSense
TM group - which reached the pre-defined
non-inferiority margin - was shown under the precondition of no
individual PVAB optimization and of programming the lowermost
PVAB. Thus, it can be postulated that the theoretical downside of
the short PVAB is fully compensated by the sensing properties of
the novel lead which effectively reduces the far-field R-wave signal
amplitudes below clinically applied sensing thresholds of the atrial
channel. This effect is most likely due to the small bipole distance
which diminishes the antenna function of the electrode.
The use of atrial leads with a very short tip-to-ring spacing
provides several benefits to clinical practice: 1) an effective
reduction of inappropriate mode switch due to FFS, 2) a time
saving in follow-up visits as no more individual adjustments of the
PVAB is needed and 3) a possible lowering of the likelihood of 2:1
lock-in of atrial flutter [15] by the application of short PVAB
intervals (median 60 ms versus 128 ms).
Apart from the superior performance in reducing FFS the leads
with 1.1 mm bipole spacing also differ in basic electrical
parameters when compared to standard electrodes. Pacing
impedances were higher in the study group; pacing thresholds
and sensing thresholds were significantly lower in the study group.
Although statistically significant, the slightly better performance
concerning the pacing threshold can hardly be interpreted as an
advantage of the lead. The observation of reduced P-wave
amplitudes remained stable over the follow-up period of three
months (2.1 mV versus 2.6 mV on average) and is in line with
previous publications [18–20]. Potentially, the smaller ‘‘antennal
Table 1. Baseline characteristics of the patients.
Study
group
Control
group P-value
(n=103) (n=101)
Age ± SD [years] 73697 4 610 0.33
Male n (%) 61 (60) 60 (60) 0.99
Pacemaker indication n (%)
Sinus node dysfunction 43 (42) 38 (38) 0.62
Atrio-ventricular block 38 (37) 46 (45)
Binodal disease 20 (19) 15 (15)
Other 2 (2) 2 (2)
History of atrial fibrillation
n( % )
34 (33) 39 (39) 0.48
Atrial lead placement n (%)
Lateral wall* 41 (40) 44 (43) 0.53
Right atrial appendage* 49 (47) 38 (38)
Other* 13 (13) 19 (19)
Fluoroscopy time ± SD [s] 3206315 3556427 0.94
Procedure time ± SD [min] 61620 62619 0.65
*According to the implanter’s judgment.
doi:10.1371/journal.pone.0038277.t001
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does not only lower the reception of far-field R-waves but may also
diminish the reception of near-field myopotentials and therefore
reduce measured P-wave amplitudes. Additionally, signals derived
from leads with a very short bipole distance may differ in
morphology from those derived from standard leads and it might
be possible that device based filters alter these signals differently.
On balance, the improved signal-to-noise ratio of a lead with a
very short tip-to-ring spacing outweigh the reduced signal
amplitudes detected for the OptiSense
TM leads during sinus
rhythm. It remains to mention that both groups of leads, the
OptiSense
TM and the standard electrodes, do not differ in
implantation and fluoroscopy time.
Limitations
Although the drop-out rate was low (two patients in each group
were lost to follow up and one patient withdrew his consent after 1
month) it cannot be excluded that this may have biased the study
result.
The atrial lead positions were – according to general clinical
practice - predominantly the atrial appendage or the lateral wall.
Therefore, we cannot comment on the lead performances and
potential detection of far-field R-wave signals at other sites such as
the lower atrial septum for which a higher risk of FFS has been
described [21,22] or for the Bachmann bundle region for which
low amplitudes of far-field R-wave signals have been reported
[23].
The study was restricted to the use of St. Jude Medical
pacemakers and leads. Although not tested, it seems likely that a
similar result would have been obtained with other pacemakers
that use a constant sensing threshold during the entire cardiac
cycle. Latest generation pacemakers of different manufacturers
enable sensing thresholds that vary during the cardiac cycle and
which also depend on the intrinsic P-wave amplitude similar to the
settings used in implantable cardioverter defibrillators. The
performance of different leads concerning FFS in these dynamic
settings warrants further investigation and the results of the present
study may not necessarily be transferable. Nevertheless, fixed
sensing thresholds still represent the most frequently applied
detection mode in pacemakers and therefore reinforce the clinical
applicability of the trial.
The follow-up was restricted to three months and therefore
long-term effects cannot be addressed by this study. Far-field R-
wave signals remained stable in their coupling intervals and
amplitudes during a three months observation period in a previous
study [8]. Considering the pathophysiology of far-field R-wave
formation [24], we believe that our results are likely to be valid
also in a mid-term follow-up provided that major atrial and
ventricular remodeling or cardiac disease progression does not
occur.
Figure 2. Inappropriate mode switch due to FFS: Stored episode depicting inappropriate mode switch due to FFS from the control
group. Despite optimized PVAB of 140 ms inappropriate mode switch occurs because the coupling interval of the far-field R-wave is 160 ms. First
line: bipolar atrial electrogram, shows bipolar atrial, second line: bipolar ventricular electrogram, bottom line: marker channel with AMS=mode
switch; AP=atrial pacing; AS=atrial sensed event; AS on black background=atrial sensed event in refractory period; VP=ventricular pacing.
doi:10.1371/journal.pone.0038277.g002
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Our data demonstrate that atrial leads characterized by a tip-to-
ring spacing of 1.1 mm avoid inappropriate mode switch caused
by far-field R-wave sensing without the need for PVAB
optimization. The same low rate of inappropriate mode switch
due to far-field R-wave sensing can be achieved with conventional
leads when the pacemaker’s PVAB is individually optimized. The
use of atrial bipolar leads with a very short tip-to-ring spacing
shows the potential to reduce the follow-up time and may increase
the validity of pacemaker diagnostic data by a short PVAB setting.
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Figure 3. Distribution of programmed PVAB during follow-up by randomization groups. Nine patients of the study group initially
received a PVAB that was erroneously programmed to a value other than 60 ms which was corrected after one month in eight of the patients and
remained prolonged in one patient. None of these patients had inappropriate mode switch due to FFS. One patient of the study group patient
exhibited inappropriate mode switch due to FFS and the PVAB was then individually optimized (150 ms). For the control group PVAB is shown as
determined to be optimal at discharge. In case of changes of the PVAB programming during the follow-up, the longest programmed PVAB for both
groups are displayed.
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Table 2. Electrical parameters of the atrial leads.
Study Group
(n=103)
Control
Group
(n=101) P-value
P-wave amplitude [mV]
At discharge 2.161.2 2.661.3 0.02
At month 1 2.161.1 2.761.3 ,0.001
At month 3 2.161.2 2.561.3 0.01
Atrial pacing threshold [V] @ 0.4 ms
At discharge 0.5760.25 0.6460.26 ,0.01
At month 1 0.6060.23 0.7260.27 ,0.001
At month 3 0.5960.18 0.7260.21 ,0.001
Atrial lead impedance [V]
At discharge 4086112 343674 ,0.001
At month 1 363667 336667 0.01
At month 3 355660 337662 0.04
doi:10.1371/journal.pone.0038277.t002
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